Elmiron Lawsuit Information
Elmiron, or pentosan polysulfate sodium (PPS), is a medication prescribed to treat pain and discomfort associated with the chronic bladder condition known as interstitial cystitis (IC). While the drug has been prescribed for decades, new studies and reports have tied long-term Elmiron use to possible retinal damage, vision loss, and blindness. Patients who took Elmiron showed unusual changes to their macula, the center of the retina responsible for clear, focused vision. Hundreds of thousands of Americans who took Elmiron could be at risk of developing maculopathy, a disease that can cause permanent vision damage.
Elmiron lawsuits have been filed, claiming that the drug causes maculopathy and other eye disorders leading to blindness. Individuals who took Elmiron and suffered vision-related side effects may be eligible to file a claim against the drug’s manufacturers. Contact an Elmiron vision loss lawyer from TorHoerman Law to learn how you may be eligible for compensation for your injuries.
Patients who were prescribed Elmiron and developed maculopathy and vision problems have accused Janssen Pharmaceuticals, the drug’s manufacturer, of failing to warn the public about the risks of ocular toxicity and potentially permanent vision damage or loss. In 2019, the American Academy of Ophthalmology researchers presented findings that showed links between PPS use and vision-threatening eye conditions and changes in the macula. If you were prescribed Elmiron and developed changes in your vision, you could be eligible for an Elmiron vision loss and blindness lawsuit. Contact an Elmiron vision loss lawyer to learn more.